Clinical trials: Moderate Hepatic Impairment

Hepatic Impairment

Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment

• Completed
• Age: All ages
• Phase 1

This study will compare the pharmacokinetics of LCQ908 in subjects with varying degrees of hepatic impairment to healthy subjects.

Trial name

NCT01594957

Testing

LCQ908

Where

2 sites in United States

Volunteers

53 people, healthy volunteers welcome

Sponsor

Novartis Pharmaceuticals